Statement of Changes in Beneficial Ownership (4)
August 05 2020 - 4:21PM
Edgar (US Regulatory)
FORM 4
[ ]
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
|
OMB APPROVAL
OMB Number:
3235-0287
Estimated average burden hours per response...
0.5
|
|
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
|
|
1. Name and Address of Reporting Person
*
Deshpande Samir |
2. Issuer Name and Ticker or Trading Symbol
HUMANA INC
[
HUM
]
|
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
_____ Director _____ 10% Owner __X__ Officer (give title below) _____ Other (specify below) Chief Tech & Risk Officer |
(Last)
(First)
(Middle)
500 WEST MAIN STREET |
3. Date of Earliest Transaction
(MM/DD/YYYY)
8/3/2020 |
(Street)
LOUISVILLE, KY 40202
(City)
(State)
(Zip)
|
4. If Amendment, Date Original Filed
(MM/DD/YYYY)
|
6. Individual or Joint/Group Filing
(Check Applicable Line)
_X
_ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person
|
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
|
1.Title of Security (Instr. 3)
|
2. Trans. Date
|
2A. Deemed Execution Date, if any
|
3. Trans. Code (Instr. 8)
|
4. Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)
|
5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)
|
6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)
|
7. Nature of Indirect Beneficial Ownership (Instr. 4)
|
Code
|
V
|
Amount
|
(A) or (D)
|
Price
|
Humana Common | 8/3/2020 | | M | | 1358 | A | $0 | 3881 | D | |
Humana Common | 8/3/2020 | | F | | 545 | D | $391.73 | 3336 | D | |
Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
|
1. Title of Derivate Security (Instr. 3) | 2. Conversion or Exercise Price of Derivative Security | 3. Trans. Date | 3A. Deemed Execution Date, if any | 4. Trans. Code (Instr. 8) | 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) | 6. Date Exercisable and Expiration Date | 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) | 8. Price of Derivative Security (Instr. 5) | 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) | 10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4) | 11. Nature of Indirect Beneficial Ownership (Instr. 4) |
Code | V | (A) | (D) | Date Exercisable | Expiration Date | Title | Amount or Number of Shares |
Options (1) | $268.47 | | | | | | | (1) | 2/19/2025 | Humana Common | 4014 | | 4014 | D | |
Options (2) | $307.965 | | | | | | | (2) | 2/25/2026 | Humana Common | 5388 | | 5388 | D | |
Options (3) | $350.7875 | | | | | | | (3) | 2/24/2027 | Humana Common | 5730 | | 5730 | D | |
Restricted Stock Units (4) | (4) | 8/3/2020 | | M | | | 1358 | (6) | (6) | Humana Common | 1358 | $0 | 0 | D | |
Restricted Stock Units (4) | (4) | | | | | | | (7) | (7) | Humana Common | 311 | | 311 | D | |
Restricted Stock Units (4) | (4) | | | | | | | (8) | (8) | Humana Common | 812 | | 812 | D | |
Restricted Stock Units (5) | (5) | | | | | | | (9) | (9) | Humana Common | 1140 | | 1140 | D | |
Explanation of Responses: |
(1) | Right to buy pursuant to Company's 2011 Stock Incentive Plan. Incentive and Non-Qualified stock options granted to reporting person on 02/19/2018, vesting in three increments from 2/19/19 to 2/19/21. |
(2) | Right to buy pursuant to Company's 2011 Stock Incentive Plan. Incentive and Non-Qualified stock options granted to reporting person on 02/25/2019, vesting in three increments from 2/25/20 to 2/25/22. |
(3) | Right to buy pursuant to Company's 2019 Amended & Restated Stock Incentive Plan. Incentive and Non-Qualified stock options granted to reporting person on 02/24/2020, vesting in three annual increments from 2/24/21 to 2/24/23. |
(4) | Right to receive one share per restricted stock unit pursuant to the Company's 2011 Stock Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1) & (3). |
(5) | Right to receive one share per restricted stock unit pursuant to the Company's 2019 Amended & Restated Stock Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1) & (3). |
(6) | Restricted stock units granted to reporting person on 08/03/2017, 33% of the award is vesting on 08/03/2018, 08/03/2019 and 08/03/2020. |
(7) | Restricted stock units granted to reporting person on 02/19/18, 33% of the award is vesting on 12/15/18, 12/15/19 and 12/15/20. |
(8) | Restricted stock units granted to reporting person on 02/25/19, 33% of the award is vesting on 12/15/19, 12/15/20 and 12/15/21. |
(9) | Restricted stock units granted to reporting person on 02/24/2020, 33% of the award is vesting on 12/15/20, 12/15/21, and 12/15/22. |
Reporting Owners
|
Reporting Owner Name / Address | Relationships |
Director | 10% Owner | Officer | Other |
Deshpande Samir 500 WEST MAIN STREET LOUISVILLE, KY 40202 |
|
| Chief Tech & Risk Officer |
|
Signatures
|
Samir M. Deshpande | | 8/5/2020 |
**Signature of Reporting Person | Date |
Humana (NYSE:HUM)
Historical Stock Chart
From Aug 2024 to Sep 2024
Humana (NYSE:HUM)
Historical Stock Chart
From Sep 2023 to Sep 2024